Boothbay Fund Management’s GlucoTrack GCTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-451
Closed -$4.31K – 2229
2026
Q2
$4.31K Hold
451
– – ﹤0.01% 2197
2026
Q1
$8.79K Hold
451
– – ﹤0.01% 1999
2025
Q4
$52.3K Buy
+451
New +$80.3K ﹤0.01% 1817

Other funds holding GCTK

Boothbay Fund Management's GCTK Position: Q3 2026 in Review

Boothbay Fund Management sold out of GlucoTrack (GCTK) in Q3 2026, closing a stake of 451 shares — an estimated $4.31K sold.

Boothbay Fund Management first reported a position in GCTK in Q4 2025 and held it in 3 quarters. The position peaked at $52.3K in Q4 2025. 8 funds tracked by Wall St. Rank hold GCTK as of Q3 2026.

  • Boothbay Fund Management reported no remaining GlucoTrack position as of Q3 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 451 GlucoTrack shares in Q3 2026, an estimated $4.31K.
  • Boothbay Fund Management first reported a position in GlucoTrack in Q4 2025 and held it in 3 quarters.
  • Boothbay Fund Management's GlucoTrack position peaked at $52.3K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held GlucoTrack as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.